The hour was defined by a stark divergence in how markets and nations value the integration of artificial intelligence. While China deepened its strategic commitment to AI, hypersonic missiles, and quantum technology to offset U.S. military advantages—viewing these as the bedrock of future, connected warfare—commercial markets exhibited caution regarding the immediate costs of that transition; software stocks including Salesforce, ServiceNow, and Intuit retreated after Figma revealed that heavy investment in AI functionality has doubled its research and development expenses. This fiscal sensitivity mirrored broader volatility in corporate results, where Onterris shares sold off following a guidance cut due to weak emergency work, and Beach Energy shares slid despite a 742% profit jump, underscoring a disjointed earnings landscape. Meanwhile, the FDA pushed the boundaries of medical innovation, approving Moderna’s first mRNA influenza vaccine and Takeda’s Orzeyful for narcolepsy, a sector buoyed by the $382.5 million IPO of Braveheart Bio. Investors are weighing these disparate developments against structural risks, with JPMorgan CEO Jamie Dimon warning that elevated market leverage and hidden borrowing could amplify potential disruptions even as gold reached a seven-week high on hopes for a deal regarding the Strait of Hormuz.